Double‐blind, randomized clinical trial comparing the efficacy and safety of continuing or discontinuing the dipeptidyl peptidase‐4 inhibitor sitagliptin when initiating insulin glargine therapy in patients with type 2 diabetes: The CompoSIT‐I Study
Roussel, Ronan, Duran‐García, Santiago, Zhang, Yilong, Shah, Suneri, Darmiento, Carolyn, Shankar, R. Ravi, Golm, Gregory T., Lam, Raymond L. H., O'Neill, Edward A., Gantz, Ira, Kaufman, Keith D., Engel, Samuel S.
Published in Diabetes, obesity & metabolism (01.04.2019)
Published in Diabetes, obesity & metabolism (01.04.2019)
Get full text
Journal Article
Corifollitropin Alfa Combined With Human Chorionic Gonadotropin in Adolescent Boys With Hypogonadotropic Hypogonadism
Shankar, R Ravi, Shah, Suneri, Joeng, Hee-Koung, Mendizabal, Geraldine, DiBello, Julia R, Guan, Yanfen, Stegmann, Barbara J, Nieschlag, Eberhard, Behre, Hermann M, Swerdloff, Ronald S, Fox, Michelle C, Kaufman, Keith D
Published in The journal of clinical endocrinology and metabolism (16.06.2022)
Published in The journal of clinical endocrinology and metabolism (16.06.2022)
Get full text
Journal Article
Efficacy and Safety of Continuing Sitagliptin when Initiating Insulin Therapy in Subjects with Type 2 Diabetes Mellitus
ROUSSEL, RONAN, DURAN-GARCIA, SANTIAGO, ZHANG, YILONG, SHAH, SUNERI, DARMIENTO, CAROLYN, RAVI SHANKAR, R., O'NEILL, EDWARD A., GOLM, GREGORY T., LAM, RAYMOND L., GANTZ, IRA, KAUFMAN, KEITH D., ENGEL, SAMUEL S.
Published in Diabetes (New York, N.Y.) (01.07.2018)
Published in Diabetes (New York, N.Y.) (01.07.2018)
Get full text
Journal Article